Medical University of Innsbruck Trials

Medical University of Innsbruck	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Simma, Burkhard

POLAR, NCT04372953 / ACTRN12618001686291: Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The Trial).

Recruiting

N/A

906

Europe, US, RoW

Positive End-Expiratory Pressure (PEEP)

Murdoch Childrens Research Institute, University of Pennsylvania, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University of Oxford

Lung Injury, Preterm Birth

11/26

05/28

NEOVASC, NCT04413994: Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors

Recruiting

N/A

200

Europe

Humavant

Prolacta Bioscience, Medical University of Vienna, Federal University Teaching Hospital, Feldkirch, Austria, Paracelsus Medical University

Prematurity, Vascular Aging

06/28

Marth, Christian

MATAO, NCT04111978: MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer

Recruiting

540

Europe

Letrozole 2.5mg, Femara, Placebo

Swiss GO Trial Group, AGO Study Group, Arbeitsgemeinschaft Gynaekologische Onkologie Austria, Reliable Cancer Therapies, Krebsliga Schweiz, Stiftung Guido Feger, Hoffmann-La Roche, Helsana AG, Novartis Pharmaceuticals, Anticancer Fund, Belgium

Ovarian Neoplasm Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms, High-grade Serous Ovarian Carcinoma (HGSOC), Low-grade Serous Ovarian Carcinoma (LGSOC), Ovarian Endometrioid Carcinoma

10/25

10/30

NCT05797831: Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Recruiting

2/3

268

Europe, Canada, US, RoW

Navtemadlin, KRT-232, Navtemadlin Placebo

Kartos Therapeutics, Inc., European Network of Gynaecological Oncological Trial Groups (ENGOT), GOG Foundation

Endometrial Cancer

08/25

07/27

SHAPE, NCT01658930: Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

Active, not recruiting

N/A

700

Europe, Canada, RoW

Radical Hysterectomy + pelvic lymph node dissection, Simple hysterectomy + pelvic lymph node dissection

Canadian Cancer Trials Group, Gynecologic Cancer Intergroup (GCIG), Canadian Institutes of Health Research (CIHR), Korean Gynecologic Oncology Group, Dutch Gynecologic Oncology Group, Cancer Trials Ireland, Arbeitsgemeinschaft Gynaekologische Onkologie Austria, Belgium Gynecologic Oncology Group, Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens, Institute of Cancer Research, United Kingdom, Shanghai Cancer Centre Deptartment of Gynecologic Oncology Fudan University, Hertzen Moscow Scientific Research Institute of Oncology, Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom Germany, Institut Claudius Regaud - Institute Universitaire du Cancer de Toulouse - Oncopole

Cervical Cancer

03/23

12/24

NCT04369352: Register to Describe the Treatment Pattern of Platinum-sensitive Relapsed Epithelial Ovarian Cancer Patients in Austria

Recruiting

N/A

150

Europe

Medical University Innsbruck

Recurrent Ovarian Carcinoma

12/24

08/25

Wolf, Dominik

LUSPLUS, NCT05181592: Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.

Recruiting

Europe

Luspatercept, Reblozyl

GWT-TUD GmbH, Celgene

Myelodysplastic Syndromes

12/24

06/25

CLL17, NCT04608318 / 2019-003854-99: Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

Active, not recruiting

897

Europe, RoW

Ibrutinib, Imbruvica, Venetoclax, ABT-199, Venclyxto, Obinutuzumab, GA101, Gazyvaro

German CLL Study Group, Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Nordic CLL Study Group (NCLLSG), Swiss Group for Clinical Cancer Research (SAKK), Cancer Trials Ireland, Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA), Grupo Español de Leucemia Linfocítica Crónica (GELLC), The Israeli CLL Study Group (ICLLSG)

Chronic Lymphoid Leukemia

03/27

DASTOP2, NCT03573596: Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment

Recruiting

134

Europe

Dasatinib

Amsterdam UMC, location VUmc, Uppsala University Hospital, Skane University Hospital, Helsinki University Central Hospital, Odense University Hospital, Henri Mondor University Hospital, St. Olavs Hospital, Helse Stavanger HF, Aarhus University Hospital, University Hospital, Bonn

CML, Relapsed

02/23

02/24

CLL-Frail, NCT04883749: Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL

Active, not recruiting

Europe

Acalabrutinib, Calquence, ACP-196

German CLL Study Group

Chronic Lymphoid Leukemia

07/23

12/24

DALY 2-EU, NCT04844866 / 2020-003908-14: Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

Recruiting

168

Europe, RoW

MB-CART2019.1, R-GemOx or BR plus polatuzumab vedotin, Rituximab, Gemcitabine, Oxaliplatin, Polatuzumab vedotin, Bendamustine, Rituximab

Miltenyi Biomedicine GmbH, ICON plc

Diffuse Large B-cell Lymphoma

12/24

07/27

PALINDROM, NCT06172894: PBMC-based Leukocyte Immunotherapy

Recruiting

Europe

APN401

invIOs GmbH

Advanced Solid Tumor

03/24

NCT06250465: AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry

Recruiting

N/A

500

Europe

Arbeitsgemeinschaft medikamentoese Tumortherapie

Chronic Lymphocytic Leukemia

12/27

InflamGen, NCT04313231: Sterile Inflammation and Molecular Aberrations in MDS

Recruiting

N/A

130

Europe

Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase chain reaction, flow cytometry, Metagenomics of stool samples, Clinical/demographic data, Elicitation of the HRQoL

Medical University Innsbruck, University Hospital, Bonn, Universitätsklinikum Leipzig

Myelodysplastic Syndromes

01/23

PRO-RED, NCT05582902: Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients

Recruiting

N/A

Europe

University of Leipzig, Deutsche Krebshilfe e.V., Bonn (Germany)

MDS, MDS/MPN

03/25

LÃ¶ffler-Ragg, Judith

NCT03626688 / 2018-001187-33: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Recruiting

1000

Europe, Canada, US, RoW

Ralinepag, APD811, Placebo

United Therapeutics

PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease

12/24

Colipris, NCT04095351: Connective Tissue Diseases and Lung Manifestations

Recruiting

N/A

120

Europe

Pulmonary function test, Imaging, Blood sampling

Medical University Innsbruck, Boehringer Ingelheim

Connective Tissue Diseases, Interstitial Lung Disease, Systemic Sclerosis

03/21

10/34

NCT04661462: Health After Covid-19 in Tyrol

Recruiting

N/A

1000

Europe

online survey

Medical University Innsbruck, Claudiana Landesfachhochschule

COVID-19

09/21

12/21

PRECISE, NCT05545332: Prospective Multidisciplinary Post-COVID-19 Registry Tyrol

Recruiting

N/A

600

Europe

Medical University Innsbruck

Post COVID-19 Condition

12/23

12/25

Virgolini, Irene

NCT06155994: 68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Completed

1/2

Europe

68Ga-DOTA-MGS5, 68Ga-labelled minigastrin analogue

Medical University Innsbruck, Novartis

Neuroendocrine Tumors

06/23

NeoRay, NCT03872778 / 2018-004727-37: [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake

Recruiting

1/2

Europe, US

[177Lu]-NeoB, Lutetium NeoB, [68Ga]-NeoB, Gallium NeoB, LCZ696, sacubitril/valsartan

Advanced Accelerator Applications

Neoplasms

11/25

12/26

Pichler, Gerhard

RR, NCT06168045: Bloodpressure and NIRS During the Immediate Transition

Recruiting

N/A

100

Europe

Cerebral tissue oxygenation and blood pressure measurement

Medical University of Graz

Blood Pressure, Cerebral Tissue Oxygenation

06/24

Kangaroo, NCT04865302: Cerebral Oxygenation in Preterm Neonates With Respiratory Support During Skin-to-skin Care on the First Day After Birth

Recruiting

N/A

Europe

SSC

Medical University of Graz

Preterm Birth, Ventilator Lung; Newborn

10/24

12/24

Figdety_Ms, NCT06105333: Fidgety Movements of Preterm Neonates Included in COSGOD III

Recruiting

N/A

183

Europe

standard care plus cerebral oxygen saturation monitoring with a dedicated treatment guideline

Medical University of Graz

Preterm, General Movements, Fidgety Movements, Near Infrared Spectroscopy, Neurological Outcome

03/24

05/24

COSGODIII-FU, NCT06141733: 2 Year Follow up of COSGOD III

Recruiting

N/A

607

Europe, Canada

NIRS group

Medical University of Graz, Medical University Innsbruck, Medical University of Vienna, Vittore Buzzi Children's Hospital, University Hospital Tuebingen, University College Cork, University Hospital Freiburg, Poznan University of Medical Sciences, University Medical Centre Ljubljana, IRCCS Burlo Garofolo, University of Alberta

Neurodevelopmental Disability, Death

12/24

HbFIN, NCT04802629: Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.

Recruiting

N/A

Europe

Near-infrared spectroscopy

Medical University of Graz

Preterm Birth, Oxygen Toxicity, Fetal Hemoglobin

05/24

pFTOE, NCT04818762: Peripheral Fractional Tissue Oxygen Extraction and Infection in Term and Preterm Neonates

Recruiting

N/A

Europe

Medical University of Graz

Neonatal Infection, Preterm Birth

12/24

02/25

Bonaros, Nikolaos

EuroECMO-COVID, NCT04366921: European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO

Recruiting

N/A

150

Europe, RoW

Maastricht University Medical Center, European chapter of the Extracorporeal Life Support Organization, Erasmus Medical Center, Leiden University Medical Center, UMC Utrecht, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Papa Giovanni XXIII Hospital, Niguarda Hospital, Ospedale San Donato, Ospedale S. Giovanni Bosco, IRCCS Policlinico S. Matteo, The Mediterranean Institute for Transplantation and Advanced Specialized Therapies, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Ospedale dell'Angelo, Venezia-Mestre, University Hospital, Udine, Italy, San Gerardo Hospital, Ospedali Riuniti Ancona, San Camillo Hospital, Rome, San Giorgio Clinic, GVM Care & Research, San Raffaele University Hospital, Italy, Ospedale San Bortolo di Vicenza, Klinik Hirslanden, Zurich, University of Zurich, Cardiocentro Ticino, Vilnius University Hospital Santaros Klinikos, Universitätsklinikum Düsseldorf, Klinikum Nürnberg, Hannover Medical School, Heart Center Leipzig - University Hospital, University Hospital Regensburg, University Hospital, Essen, German Heart Center, University Hospital, Aachen, University Heart Center Freiburg - Bad Krozingen, Klinikum Kassel, General University Hospital, Prague, Universitaire Ziekenhuizen Leuven, Onze Lieve Vrouwziekenhuis Aalst, Erasme University Hospital, University Hospital, Antwerp, Hôpital Civil Marie Curie de Charleroi, University Hospital, Ghent, Centre Hospitalier Universitaire Saint Pierre, Hospital Vall d'Hebron, Hospital Universitario Ramon y Cajal, Hospital Miguel Servet, Henri Mondor University Hospital, Hospices Civils de Lyon, Pitié-Salpêtrière Hospital, Rennes University Hospital, Guy's and St Thomas' NHS Foundation Trust, Karolinska University Hospital, Hospital Sao Joao, Medical University of Warsaw, Universitätskliniken Innsbruck, Medical University of Vienna, University Hospital, Alexandroupolis, Novosibirsk City Hospital #2, City Clinical Hospital No. 67, Moscow, Russia, City Hospital No 40, Saint Petersburg, Russia, Krasnodar Regional Hospital no 1, Kemerovo Regional Clinical Cardiological Center named after academician L.S. Barbarash, City Hospital No 41, Ekaterinburg, Russia, G. Pasquinucci Heart Hospital, Massa, Charles University, Czech Republic, University Hospital, Bordeaux, Bambino Gesù Hospital and Research Institute, Policlinico Hospital Milan, Gaslini Children's Hospital, Children's Medical Hospital, University of Essen, Essen, Germany, University Hospital, Geneva, Newcastle-upon-Tyne Hospitals NHS Trust, Paediatric Intensive Care Glasgow, Paris South University Hospitals, University of Groningen, Great Ormond Street Hospital for Children NHS Foundation Trust, Hospital Sant Joan de Deu, Heim Pal Children's Hospital, University Hospital, Montpellier, Royal Brompton & Harefield NHS Foundation Trust, Lund University Hospital, Landesklinikum Sankt Polten, Chelyabinsk Regional Clinical Hospital, ECMO Centers Israel, Copenhagen University Hospital at Herlev, Ospedale M. Bufalini Cesena, A.O.U. Città della Salute e della Scienza - Molinette Hospital, Mauriziano Umberto I Hospital, University of Bern, University Hospital, Basel, Switzerland, University of Lausanne Hospitals, University Hospital Tuebingen, Universitätsklinikum Köln, Chirec, Universitair Ziekenhuis Brussel, Centre Hospitalier Universitaire de Liège, La Louvière Hopital, Leicester Royal Infirmary NHS Trust

COVID, SARS-CoV-2, ARDS, Human, Refractory Hypoxemia, Cardiogenic Shock, Septic Shock, Extracorporeal Membrane Oxygenation

04/22

NCT04775108: First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve System

Recruiting

N/A

Europe, RoW

Epygon™ Transcatheter Mitral Valve System

Epygon

Mitral Valve Regurgitation

10/24

12/29

MANTRA, NCT05002543: CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting

Recruiting

N/A

2150

Europe, Canada, US, RoW

Corcym S.r.l

Cardiac Valve Disease

08/25

12/35

HARVITA, NCT05931783: Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery

Recruiting

N/A

1350

Europe

skeletonized harvesting technique, pedicled harvesting technique

Medical University Innsbruck

Coronary Artery Disease

10/28

10/31

Beer, Ronny

ENRICH-AF, NCT03950076 / 2019-002075-33: EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation

Recruiting

1200

Europe, Canada, US, RoW

Edoxaban, Lixiana, Savaysa, Non-anticoagulant medical therapy

Population Health Research Institute

Intracranial Hemorrhages, Atrial Fibrillation

10/24

Schmid, Stefan

NCT05679635: Evaluation of Tracheal Pressure During CPAP

Completed

N/A

Europe

Evone, Evita Infinity V500

Medical University Innsbruck

Continuous Positive Airway Pressure, CPAP Ventilation

05/24

NCT06104995: Back Beliefs Among the General Population

Not yet recruiting

N/A

200

Interventional video, Control video

Bern University of Applied Sciences, Haute Ecole de Santé Vaud

Low Back Pain

01/24

05/24

Benesch, Martin

AIEOP-BFM ALL 2017, NCT03643276 / 2016-001935-12: Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia -

Recruiting

5000

Europe, RoW

Blinatumomab, Bortezomib, Cyclophosphamide, Cytarabine, Daunorubicin, Myocet, Dexamethasone, Doxorubicin, Etoposide, Fludarabine Phosphate, Ifosfamide, 6-Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Tioguanin, Vincristine, Vindesine, Erwinase

Martin Schrappe, Deutsche Krebshilfe e.V., Bonn (Germany)

Acute Lymphoblastic Leukemia, Pediatric

07/28

SIOP-EP-II, NCT02265770 / 2013-002766-39: An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma

Recruiting

2/3

536

Europe, RoW

16 weeks of VEC + CDDP, Vincristine, Etoposide, Cyclophosphamide, Cisplatin, VEC + HD-MTX, Methotrexate, Chemotherapy + Valproate, Carboplatin, Valproate, Conformal radiotherapy, VEC, Chemotherapy, conformal radiotherapy +/- boost

Centre Leon Berard

Childhood Ependymoma

06/28

08/31

MEMMAT, NCT01356290 / 2010-023691-33: Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT

Recruiting

100

Europe, US, RoW

Bevacizumab, Avastin, Thalidomide, Celecoxib, Fenofibric acid, Etoposide, Cyclophosphamide, Etoposide phosphate, Cytarabine

Medical University of Vienna

Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent

04/26

Schneeberger, Stefan

NCT04311632: A Dose Escalation Study in de Novo Renal Transplantation

Completed

TCD601, Tacrolimus (TAC), Corticosteroids (CS), Mycophenolate Mofetil (MMF), ATG

ITB-Med LLC

Kidney Transplantation

10/23

Marschang, Peter

ANGLE, NCT03044704: Haemodynamic and Geometric Factors in Atherosclerosis

Active, not recruiting

N/A

100

Europe

Medical University Innsbruck

Atherosclerosis

11/19

01/28

NCT01895725: Correlation of Artherosclerotic Plaque Volume and Intima Media Thickness With Soluble P-selectin

Active, not recruiting

N/A

443

Europe

Medical University Innsbruck

Cardiovascular Risk Factors, Coronary Artery Disease, Cerebrovascular Disease, Peripheral Artery Disease

01/20

01/28

Meister, Bernhard

NCT01728155: European Low and Intermediate Risk Neuroblastoma Protocol

Completed

685

Europe, RoW

chemotherapy

Instituto de Investigacion Sanitaria La Fe

LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES

12/22

AIEOP-BFM ALL 2017, NCT03643276 / 2016-001935-12: Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia -

Recruiting

5000

Europe, RoW

Martin Schrappe, Deutsche Krebshilfe e.V., Bonn (Germany)

Acute Lymphoblastic Leukemia, Pediatric

07/28

FORUM, NCT01949129 / 2012-003032-22: Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Recruiting

2/3

1800

Europe, Canada, RoW

VP16, Etoposide, TBI, Thiotepa, Thio, Treosulfan, Treo, Fludarabine, Flu, Busulfan, Bu, ATG Thymoglobulin, ATG Thymo, Cyclophosphamide, Cy, Grafalon, Anti-human T-lymphocyte immunoglobulin

St. Anna Kinderkrebsforschung, ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group

Acute Lymphoblastic Leukaemia

06/25

04/30

Schreinlechner, Michael

TELE-CARDIO, NCT05485532: Development and Validation of a Telemonitoring System for High-risk Cardiovascular Patients

Recruiting

N/A

1000

Europe

Telemonitoring System using Cosinuss° Two and/or Garmin Vivoactive 4

Medical University Innsbruck

Cardiovascular Diseases

01/25

01/28

riskINN, NCT05472207: "Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease"

Recruiting

N/A

5000

Europe

Medical University Innsbruck

Cardiovascular Diseases, Healthy

01/25

01/30

Zoller, Heinz

NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting

1000

Europe, Canada, US, RoW

IVA337, Lanifibranor, Placebo

Inventiva Pharma

NASH - Nonalcoholic Steatohepatitis

09/25

09/26

Hubalek, Michael

EMBER-3, NCT04975308 / 2021-000079-35: A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

Recruiting

860

Europe, Japan, US, RoW

Imlunestrant, LY3484356, Exemestane, Fulvestrant, Abemaciclib, LY2835219

Eli Lilly and Company, Eli Lilly and Company

Breast Neoplasms, Neoplasm Metastasis

04/24

08/27

HER2CLIMB-05, NCT05132582 / 2021-002491-39: A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

Recruiting

650

Europe, Canada, Japan, US, RoW

Tucatinib, TUKYSA, ONT-380, ARRY-380, Trastuzumab, Herceptin, Herceptin Hylecta, Pertuzumab, Perjeta, Combination product: Trastuzumab + Pertuzumab, Phesgo, Placebo

Seagen Inc., Merck Sharp & Dohme LLC

HER2 Positive Breast Cancer

10/24

06/27

EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Recruiting

6000

Europe, Canada, Japan, US, RoW

Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane

Eli Lilly and Company

Breast Neoplasms

10/27

03/32

Kiechl-Kohlendorfer, Ursula

EVA4YOU, NCT04598685: Early Vascular Ageing in the YOUth

Completed

N/A

1517

Europe

VASCage GmbH, Medical University Innsbruck, Tirol Kiniken GmbH

Atherosclerosis, Cardiovascular Risk Factor, Cardiovascular Diseases, Cardiovascular Pathology, Life Style, Vascular Diseases, Vascular Stiffness, Non-Alcoholic Fatty Liver Disease, Hypertension, Obesity, Overweight, Headache, Sleep, Sleep Disorder

02/23

03/23

Figdety_Ms, NCT06105333: Fidgety Movements of Preterm Neonates Included in COSGOD III

Recruiting

N/A

183

Europe

standard care plus cerebral oxygen saturation monitoring with a dedicated treatment guideline

Medical University of Graz

Preterm, General Movements, Fidgety Movements, Near Infrared Spectroscopy, Neurological Outcome

03/24

05/24

COSGODIII-FU, NCT06141733: 2 Year Follow up of COSGOD III

Recruiting

N/A

607

Europe, Canada

NIRS group

Neurodevelopmental Disability, Death

12/24

NEOVASC, NCT04413994: Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors

Recruiting

N/A

200

Europe

Humavant

Prolacta Bioscience, Medical University of Vienna, Federal University Teaching Hospital, Feldkirch, Austria, Paracelsus Medical University

Prematurity, Vascular Aging

06/28

Ennemoser, Yvonne

MEMMAT, NCT01356290 / 2010-023691-33: Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT

Recruiting

100

Europe, US, RoW

Bevacizumab, Avastin, Thalidomide, Celecoxib, Fenofibric acid, Etoposide, Cyclophosphamide, Etoposide phosphate, Cytarabine

Medical University of Vienna

Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent

04/26

Freyschlag, Christian

METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Active, not recruiting

270

Europe, Canada, US, RoW

NovoTTF-200M device, Best Standard of Care

NovoCure GmbH

Brain Metastases From Non-small Cell Lung Cancer (NSCLC)

12/24

RESURGE, NCT02394626: Surgery for Recurrent Glioblastoma

Recruiting

120

Europe

Surgery followed by adjuvant second-line therapy, Second-line therapy alone

Insel Gruppe AG, University Hospital Bern, European Organisation for Research and Treatment of Cancer - EORTC

Glioblastoma

12/25

PREVAIL, NCT04490161: Prevention of Vasospasm in SAH Through CSF Treatment

Recruiting

N/A

Europe

intravenous reinstallation of cerebrospinal fluid

Medical University Innsbruck

Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal, Vasospasm, Cerebral, Aneurysmal Subarachnoid Hemorrhage

12/23

06/24

Weiss, GÃ¼nter

ACOVACT, NCT04351724 / 2020-001302-30: Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)

Recruiting

2/3

500

Europe

Chloroquine or Hydroxychloroquine, Lopinavir/Ritonavir, Best standard of care, Rivaroxaban, Thromboprophylaxis, Candesartan, non-RAS blocking antihypertensives, Remdesivir, Asunercept 400mg, Asunercept 100mg, Asunercept 25mg, Pentaglobin

Medical University of Vienna, Kaiser Franz Josef Hospital, SMZ-Ost Donauspital, Otto Wagner Hospital, Hospital Hietzing, Wilhelminenspital Vienna, Medical University Innsbruck, Medical University of Graz, Kepler University Hospital

COVID-19

12/21

03/22

Crazzolara, Roman

MEMMAT, NCT01356290 / 2010-023691-33: Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT

Recruiting

100

Europe, US, RoW

Bevacizumab, Avastin, Thalidomide, Celecoxib, Fenofibric acid, Etoposide, Cyclophosphamide, Etoposide phosphate, Cytarabine

Medical University of Vienna

Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent

04/26

Heim, Beatrice

NCT05421221: Olfactory Training in COVID-19 Associated Loss of Smell

Not yet recruiting

N/A

100

Europe

Sniffin' sticks Duftquartett

Medical University Innsbruck

COVID-19, Hyposmia

08/23

12/23

NCT05401773: Î±-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19

Recruiting

N/A

200

Europe

Real-time Quaking-Induced Conversion (RT-QuIC)

Medical University Innsbruck

COVID-19

12/23

Kapferer-Seebacher, Ines

NCT06327841: Plaque Reduction Sesame Oil

Completed

N/A

Europe

sesame oil, distilled water

Medical University Innsbruck

Dental Plaque, Gingivitis, Oral Microbial Colonization

08/22

Kampen, Paulien M van

EUROSPIN, NCT03398915: The European Robotic Spinal Instrumentation () Study

Recruiting

N/A

615

Europe

Transpedicular Instrumentation

Marc Schröder

Degenerative Disc Disease, Spondylolisthesis, Spinal Stenosis, Recurrent Disc Herniation, Spondylodiskitis, Spinal Tumor, Spinal Metastases

09/21

09/23

Girod, Pierre-Pascal

EUROSPIN, NCT03398915: The European Robotic Spinal Instrumentation () Study

Recruiting

N/A

615

Europe

Transpedicular Instrumentation

Marc Schröder

Degenerative Disc Disease, Spondylolisthesis, Spinal Stenosis, Recurrent Disc Herniation, Spondylodiskitis, Spinal Tumor, Spinal Metastases

09/21

09/23

Lass-FlÃ¶rl, Cornelia

BIMI, NCT04720144: Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis

Recruiting

N/A

300

Europe

Centre Hospitalier Universitaire Vaudois

Invasive Mold Infections, Breakthrough Invasive Mold Infections, Hematologic Malignancy, Hematologic Diseases

09/22

PHENOTECH-1, NCT05613322: Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

Recruiting

N/A

250

Europe

Resistell Phenotech

Resistell AG

Bacteremia Sepsis

07/24

Knoflach, Michael

EVA4YOU, NCT04598685: Early Vascular Ageing in the YOUth

Completed

N/A

1517

Europe

VASCage GmbH, Medical University Innsbruck, Tirol Kiniken GmbH

02/23

03/23

healthy tyrol, NCT04749004: A Randomized-Controlled Lifestyle Intervention to Increase Physical Activity Levels in Adolescents

Completed

N/A

373

Europe

Promotion of physical activity

VASCage GmbH, Management Center Innsbruck, Medical University Innsbruck, Tirol Kiniken GmbH

Life Style, Healthy, Life Style

02/23

03/23

NCT04845269: Post-Stroke Osteopathy

Completed

N/A

127

Europe

VASCage GmbH, Medical University Innsbruck

Stroke (CVA) or TIA, Fracture, Fall

05/23

NCT05741827: YOUhealTH - a Study to Improve Cardiovascular Health in Adolescents and Adults

Recruiting

N/A

450

Europe

Lifestyle intervention

VASCage GmbH

Cardiovascular Diseases, Atherosclerosis

05/24

12/24

NCT05273216: Reperfusion Injury After Endovascular Stroke Treatment

Recruiting

N/A

600

Europe

Transcranial Duplex Sonography, Brain MRI, Blood biomarkers

Medical University of Graz, Medical University Innsbruck, Paracelsus Medical University

Ischemic Stroke

10/24

04/25

NCT04582825: Stroke-Card Registry

Recruiting

N/A

5000

Europe

N/A - Observational Study

VASCage GmbH, Medical University Innsbruck, St John of God Hospital, Vienna

Ischemic Stroke, Transient Ischemic Attack

07/27

Koch, Robert

NCT05507203: ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1

Recruiting

612

Europe, Canada, US, RoW

ABX464, Obefazimod, Placebo

Abivax S.A.

Ulcerative Colitis

12/24

02/25

LUCENT-URGE, NCT05767021: A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

Recruiting

160

Europe, US, RoW

Mirikizumab, LY3074828

Eli Lilly and Company

Ulcerative Colitis, Ulcerative Colitis Chronic

12/24

03/25

VIVID-2, NCT04232553 / 2019-002687-27: A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Recruiting

778

Europe, Canada, Japan, US, RoW

Mirikizumab, LY3074828

Eli Lilly and Company

Crohn's Disease

01/25

12/26

NCT05535946: ABTECT - Maintenance

Recruiting

1050

Europe, Canada, Japan, US, RoW

ABX464, Obefazimod, Placebo

Abivax S.A.

Ulcerative Colitis

01/26

06/26

LUCENT-3, NCT03519945 / 2017-004092-31: A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Jan 2022 - Mar 2022 : Data from LUCENT 3 trial for moderate-to-severe ulcerative colitis

Recruiting

1063

Europe, Canada, Japan, US, RoW

Mirikizumab, LY3074828

Eli Lilly and Company

Ulcerative Colitis

07/26

12/27

Binder, Christoph

MUC-FIRE, NCT03469609: Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("" Trial)

Recruiting

N/A

120

Europe

mucous fistula refeeding

University of Leipzig, German Research Foundation, Hannover Medical School

Enterostomy

11/24

NEOVASC, NCT04413994: Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors

Recruiting

N/A

200

Europe

Humavant

Prolacta Bioscience, Medical University of Vienna, Federal University Teaching Hospital, Feldkirch, Austria, Paracelsus Medical University

Prematurity, Vascular Aging

06/28

Spraider, Patrick

NCT05679635: Evaluation of Tracheal Pressure During CPAP

Completed

N/A

Europe

Evone, Evita Infinity V500

Medical University Innsbruck

Continuous Positive Airway Pressure, CPAP Ventilation

05/24

POWER-FLOW, NCT06222463: Power Dissipation in Flow-controlled Ventilation

Recruiting

N/A

Europe

Evone

Medical University Innsbruck

Mechanical Ventilation, Abdominal Surgery

04/25

05/25

NCT05946707: Effects of Oxygen Supply After Lung Isolation in Thoracic Surgery

Completed

N/A

Europe

restrictive oxygen supply, liberal oxygen supply

Medical University Innsbruck

Mechanical Ventilation, Thoracic Surgery, One-Lung Ventilation

03/24

Abram, Julia

NCT05679635: Evaluation of Tracheal Pressure During CPAP

Completed

N/A

Europe

Evone, Evita Infinity V500

Medical University Innsbruck

Continuous Positive Airway Pressure, CPAP Ventilation

05/24

NCT05946707: Effects of Oxygen Supply After Lung Isolation in Thoracic Surgery

Completed

N/A

Europe

restrictive oxygen supply, liberal oxygen supply

Medical University Innsbruck

Mechanical Ventilation, Thoracic Surgery, One-Lung Ventilation

03/24

Tancevski, Ivan

PROMETHEos, NCT04538937: Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils

Recruiting

N/A

300

Europe

no intervention

Medical University Innsbruck

Eosinophilic Asthma, EGPA - Eosinophilic Granulomatosis With Polyangiitis, Samter Triad, HES - Hypereosinophilic Syndrome, Eosinophilic Pneumonia

02/21

02/30

Wald, Martin

NEOVASC, NCT04413994: Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors

Recruiting

N/A

200

Europe

Humavant

Prolacta Bioscience, Medical University of Vienna, Federal University Teaching Hospital, Feldkirch, Austria, Paracelsus Medical University

Prematurity, Vascular Aging

06/28

Wolf, Domink

InflamGen, NCT04313231: Sterile Inflammation and Molecular Aberrations in MDS

Recruiting

N/A

130

Europe

Medical University Innsbruck, University Hospital, Bonn, Universitätsklinikum Leipzig

Myelodysplastic Syndromes

01/23

Stauder, Reinhard

aMYELOIDr, NCT04438889: Austrian Myeloid Registry

Recruiting

N/A

3000

Europe

Non-interventional

Arbeitsgemeinschaft medikamentoese Tumortherapie

Myeloid Diseases

04/29

04/30

NCT04649320: Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias

Recruiting

N/A

300

Europe

questionnaire

Medical University Innsbruck

Covid19

12/20

Bonaros, Nikolaus

NCT04761068: Clinical Outcomes of Patients Undergoing CABG Surgery With VEST Supported Venous Grafts

Recruiting

N/A

1000

Europe

VEST

Cardiocentro Ticino

Coronary Artery Disease

03/26

FREISTRITZER

API-CAT, NCT03692065 / 2017-003342-25: STUDY for APIxaban Cancer Associated Thrombosis

Active, not recruiting

1767

Europe, Canada

Apixaban 5 MG, Apixaban 2.5 MG

Assistance Publique - Hôpitaux de Paris, Bristol-Myers Squibb

Cancer-associated Thrombosis

09/24

10/24

Laer, Dorothee von

HeVacc, NCT04907331: Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2

Recruiting

3000

Europe

Vaxzevria, Comirnaty

Medical University Innsbruck, Medical University of Graz, Medical University of Vienna

SARS-CoV2 Infection

11/21

12/21

Petr, Ondra

DUAL-ICP, NCT05346471: Infra- and Supratentorial Neuromonitoring

Recruiting

N/A

Europe

Multimodal neuromonitoring

Medical University Innsbruck

Intracranial Pressure Increase, Posterior Fossa Lesion, Posterior Fossa Hemorrhage

12/24

03/25

Veldt, Astrid van der

KEYNOTE-D18, NCT05155254 / 2021-004594-32: IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

Active, not recruiting

407

Europe, US, RoW

IO102-IO103, Pembrolizumab

IO Biotech, Syneos Health, Merck Sharp & Dohme LLC

Metastatic Melanoma, Unresectable Melanoma

07/25

09/27

MARIANE, NCT06240143: Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma

Not yet recruiting

1/2

Europe

Ipilimumab, Nivolumab

The Netherlands Cancer Institute

Melanoma

02/26

05/26

NeoRay, NCT03872778 / 2018-004727-37: [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake

Recruiting

1/2

Europe, US

[177Lu]-NeoB, Lutetium NeoB, [68Ga]-NeoB, Gallium NeoB, LCZ696, sacubitril/valsartan

Advanced Accelerator Applications

Neoplasms

11/25

12/26

NCT05652673: Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Recruiting

N/A

Europe

nivolumab

Erasmus Medical Center

Melanoma Stage IV, Melanoma Stage III, Immunotherapy, Toxicity, Drug

12/25

12/29

Michel, Miriam

NCT04764305: Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient a Metabolomics and Proteomics Approach

Recruiting

N/A

300

Europe

Medical University Innsbruck, Heart and Diabetes Center North Rhine-Westphalia, Austrian Science Fund (FWF)

Patient Participation, Heart Defects, Congenital, Liver Diseases, Collateral Circulation, Any Site, Myocardial Fibrosis

12/25

Rugg, Christopher

NCT05679635: Evaluation of Tracheal Pressure During CPAP

Completed

N/A

Europe

Evone, Evita Infinity V500

Medical University Innsbruck

Continuous Positive Airway Pressure, CPAP Ventilation

05/24

PhINEST, NCT03840395: The Study - Pharyngeal ICU Novel Electrical Stimulation Therapy

Recruiting

N/A

360

Europe

Pharyngeal Electrical Stimulation (PES), Phagenyx

Phagenesis Ltd., NAMSA, Cytel Inc.

Dysphagia

04/25

12/25



	Diseases Companies Products Productz Mechanisms of Action Sites